SB 2534 (Veteran Families Health Services Act of 2025) directs the Department of Defense and the Department of Veterans Affairs to broaden reproductive health supports for active-duty service members, veterans, and their spouses, partners, gamete donors, and gestational surrogates. The bill covers a range of clinical services—counseling, assisted reproductive technologies, cryopreservation and storage of reproductive genetic material, and certain adoption supports—and requires agencies to coordinate care and transition planning.
This is a federal baseline for reproductive assistance tied to military service and veteran enrollment. For health systems, benefits administrators, and fertility providers it creates new eligibility pathways, reimbursement responsibilities, and operational duties (storage, navigation, and interagency coordination) that will affect military treatment facilities, VA medical centers, and private clinics that contract with them.
At a Glance
What It Does
The bill requires the Secretary of Defense to make fertility treatment and counseling available to active-duty members and their spouses, partners, or gestational surrogates, and requires the Secretary of Veterans Affairs to furnish fertility treatment and counseling to enrolled veterans and their eligible partners. For in vitro fertilization, the statute authorizes up to three completed oocyte retrievals per individual and permits unlimited embryo transfers. It also mandates cryopreservation opportunities before deployment or hazardous assignments and directs both agencies to establish regulations within two years.
Who It Affects
Directly affected parties include active-duty service members, enrolled veterans, spouses/partners, gestational surrogates, gamete donors, military and VA clinicians, and private fertility clinics and cryobanks that contract with DoD or VA. Health systems that manage continuum-of-care during Permanent Change of Station or veteran transition will have new coordination duties.
Why It Matters
The bill sets a single federal floor for reproductive assistance linked to military service and veteran enrollment—potentially shifting funding and capacity requirements to DoD, VA, and partner providers. It also creates an explicit pathway for preserving reproductive options after combat injuries, hazardous exposures, and during transition out of service, with knock-on effects for procurement, storage logistics, and interagency billing.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 2534 changes both how and when the federal military health system steps in on reproductive care. For active-duty members the Department of Defense must offer counseling and a broad menu of fertility services—from gamete preservation and assisted reproductive technology (including IVF) to genetic testing of embryos and fertility-related medications—without discriminating on sex, gender identity, sexual orientation, infertility diagnosis, or marital status.
The bill lets members elect to use donor gametes when they cannot provide their own, and requires DoD to pay or reimburse reasonable costs to obtain donated material.
The bill adds procedural protections around preservation. DoD must establish rapid retrieval procedures after injury or illness that threatens fertility and offer pre-deployment or pre-hazardous assignment cryopreservation, including for assignments with PFAS exposure risk.
Cryopreservation, testing, shipping, and storage for active-duty members must be provided at no cost through the date one year after separation, retirement, or release; after that year the individual can either continue storage at their expense or transfer material to a private facility. The statute also requires advance medical directives and military testamentary instruments to include questions about consent, ownership, and future use of cryopreserved material.For veterans, the VA will treat fertility treatment and counseling as medical services and furnish them to enrolled veterans and their consenting partners, donors, or gestational surrogates.
The VA may reimburse reasonable donor procurement costs and may cover reasonable travel/incidental expenses tied to obtaining donor material. The VA may only provide these services to veterans who are required to pay copayments if the veteran consents to pay the applicable copayment for the fertility care.
The bill creates a narrow adoption-assistance authority for covered veterans, limits that assistance to an amount the Secretary defines (tied administratively to the cost of up to three adoptions), and directs outreach and training so providers and veterans know what’s covered.Operationally, the statute expects DoD and VA to coordinate: they must share best practices, facilitate referrals, and enter a memorandum of understanding to manage continuity of care for service members transitioning to veteran status and to allow the VA to compensate DoD for cryopreservation, transport, and storage when appropriate. The VA also gets a mandate to facilitate collaborative reproduction and infertility research (in conjunction with DoD and HHS) and to disseminate findings across the Veterans Health Administration.
Both Secretaries must issue implementing regulations within two years of enactment.
The Five Things You Need to Know
The statute authorizes up to three completed oocyte retrievals per individual for IVF and allows unlimited embryo transfers.
DoD must provide retrieval, cryopreservation, testing, shipping, and storage at no cost through one year after a member’s retirement, separation, or release from service.
If a service member cannot supply reproductive genetic material, the department must permit use of donor material and pay or reimburse reasonable donor procurement costs.
VA fertility benefits are available to enrolled (covered) veterans and their consenting spouses, partners, gamete donors, or gestational surrogates, but VA will only furnish care involving copayments if the veteran agrees to pay the applicable copayment.
The bill creates an adoption-assistance authority for covered veterans capped at an amount the Secretary determines equivalent to paying the expenses of up to three adoptions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
DoD fertility treatment and counseling for members and partners
This section instructs the Secretary of Defense to make fertility treatment and counseling available to active-duty members and selected family/partner categories and explicitly bars eligibility discrimination by sex, gender identity, sexual orientation, sex characteristics, infertility diagnosis, or marital status. It lists covered services (preservation, artificial insemination, ART including IVF, embryo testing, medications, and gamete donation) and gives the Secretary authority to set IVF delivery limits—textually capped at three completed oocyte retrievals and unlimited embryo transfers. The section also clarifies that DoD is not required to find or certify gestational surrogates or donors for members.
Fertility preservation after injury and pre-hazard cryopreservation
The bill requires DoD to institute procedures for rapid retrieval of reproductive material when an injury or illness occurring on active duty risks fertility, and to offer retrieval and cryopreservation before deployment or hazardous assignments (explicitly calling out PFAS exposure). It mandates free initial storage and handling through one year post-separation, then gives individuals a choice to continue storage at their own cost or transfer to a private facility. These provisions create operational load for military treatment facilities and contracting with cryobanks.
Navigation, interagency coordination, and rulemaking
DoD must help members navigate services, find appropriate providers, and maintain continuity during Permanent Change of Station. The Secretary must coordinate with VA, share best practices, and negotiate an MOU to manage transitions; DoD must promulgate regulations within two years. The MOU can authorize VA to reimburse DoD for cryostorage costs when veterans transition, which creates a bill-back and accounting requirement between agencies.
VA medical-service definition and fertility treatment for enrolled veterans
Section 201 amends the VA medical-service definition to include fertility treatment and counseling. Section 202 adds a new statutory entitlement: the VA must furnish fertility treatment and counseling to covered veterans and their consenting partners, donors, or gestational surrogates. The VA may reimburse donor procurement and reasonable travel/incidental costs; however, when a veteran’s status carries VA copay obligations, the VA may only provide fertility services tied to copays if the veteran agrees to pay them. The VA’s role is expressly limited on custody or disposition disputes—those are left to private parties and facilities.
Adoption assistance, research facilitation, and VA rulemaking
The bill authorizes a new adoption-assistance payment for covered veterans, capped administratively at an amount equal to the Department’s cost for up to three adoptions. It directs the VA to facilitate collaborative reproduction and infertility research (working with DoD and HHS) and to disseminate findings across the VHA. Finally, the VA must issue implementing regulations within two years for the new fertility and adoption authorities.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Active-duty service members and their selected partners — they gain access to fertility counseling, preservation, and ART options tied to service events (deployment, hazardous duty, injury) that preserve family-forming choices after service-related harms.
- Enrolled veterans and their consenting partners/gamete donors/gestational surrogates — they get an explicit VA pathway to fertility treatment and counseling and possible reimbursement for donor procurement and travel tied to donor acquisition.
- Families of service members and veterans — adoption assistance and clearer rules on preservation/transfer of cryopreserved material give families more predictable options after injury or death.
- Fertility clinics and cryobanks contracting with DoD or VA — expected new volume for retrieval, cryostorage, testing, and embryo services as federal demand grows.
- Researchers and public health programs — mandated DoD–VA–HHS collaboration and dissemination can expand evidence about military-specific reproductive harms (e.g., toxic exposures) and fertility outcomes.
Who Bears the Cost
- Department of Defense and military health system — must stand up retrieval, cryopreservation, storage logistics, contracting with private cryobanks, navigation assistance, and rapid-post-injury protocols (upfront operational and contract costs).
- Department of Veterans Affairs — will absorb costs for fertility treatment counseling, donor reimbursements (where applicable), outreach/training, research facilitation, and possibly reimbursing DoD for storage after transition per the MOU.
- Private fertility providers and cryobanks — will need to scale capacity, comply with federal contracting and VA/DoD referral protocols, and potentially accept federal payment terms and reporting requirements.
- Covered veterans with copay obligations — may need to pay VA copayments for fertility services if they are in a copay tier and consent to receive services.
- Agency budget offices and appropriators — the statute creates new, recurring service and potential reimbursement obligations that will pressure DoD and VA budgets and require appropriation or reprogramming decisions.
Key Issues
The Core Tension
The central tension is between establishing broad, equitable access to reproductive services tied to military service (preserving family-building options and addressing service-related harms) and the practical limits of delivering and financing those services across two large federal systems. The statute expands entitlement-style benefits but leaves implementation, cost-allocation, and dispute resolution largely to agency rulemaking and private arrangements—so it solves access questions on paper while transferring complex operational, fiscal, and legal choices to later stages.
The bill solves a clear access problem but raises operational and legal frictions. Implementation requires DoD and VA to build clinical pathways (rapid retrieval, storage, IVF cycles), set contracting relationships with private cryobanks and clinics, and develop bill-back MOU arrangements—each a nontrivial procurement, privacy, and chain-of-custody task.
Cryopreservation and later disposition raise thorny consent and property questions; the statute pushes those disputes into private arrangements and advance directives, but it does not create a uniform federal standard for resolving contested ownership or posthumous use beyond requiring explicit choices in military testamentary instruments. That gap leaves states’ family- or probate-law variation and private-contract terms to govern many outcomes.
Financially, the bill spreads costs across three buckets—DoD operational outlays while a member is active, VA benefits for enrolled veterans, and private parties if individuals elect continued storage—yet it leaves key budget triggers undefined. The VA can require copayments in eligible tiers only with veteran consent, which shifts some cost to veterans but also may limit access for lower-income enrolled veterans who cannot or will not pay.
Regulatory drafting will be consequential: rulemaking choices about what constitutes ‘‘reasonable’’ donor procurement costs, what counts as hazardous assignments, and how to operationalize unlimited embryo transfers versus other clinical limits will materially shape utilization and program costs.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.